MyoKardia, Inc.. (MYOK) NASDAQ
$224.91 - (-)
Market Cap: $11.99B
As of 11/16/20 12:00 AM EST. Market closed.
MyoKardia, Inc.. (MYOK)
NASDAQ
$224.91
- (-)
Market Cap: $11.99B
As of 11/16/20 12:00 AM EST. Market closed.
Add to Portfolio
MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by ... read more
MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. read less
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Anastasios E. Gianakakos
Full Time Employees
235
CEO Compensation (Base)
$569,204
CEO Compensation (Total)
$8.97M
Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Anastasios E. Gianakakos
Full Time Employees
235
CEO Compensation (Base)
$569,204
CEO Compensation (Total)
$8.97M
Address
1000 Sierra Point Parkway, CA, Brisbane, 94005.
PRICE CHART FOR MYOKARDIA, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$224.91
Days Range
- - -
52 week range
$42.65 - $225
Volume
0
Avg. Volume (30 days)
1,352,939
Market Cap
$11.99B
Dividend Yield
-
P/E
-
Shares Outstanding
53,322,900
Open
-
Previous Close
$224.91
Days Range
- - -
52 week range
$42.65 - $225
Volume
0
Avg. Volume (30 days)
1,352,939
Market Cap
$11.99B
Dividend Yield
-
P/E
-
Shares Outstanding
53,322,900
FINANCIAL STATEMENTS FOR MYOKARDIA, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MYOKARDIA, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| CRANSTON MARY B | Director | Jun 30, 2020 | Option Exercise | $11.69 | 21,629 | 252,843 | 23,929 | Oct 30, 2020, 08:56 PM |
| CRANSTON MARY B | Director | Jun 29, 2020 | Option Exercise | $11.69 | 371 | 4,337 | 2,671 | Oct 30, 2020, 08:56 PM |
| CRANSTON MARY B | Director | Jun 30, 2020 | Sale | $96.60 | 21,629 | 2,089,355 | 23,629 | Oct 30, 2020, 08:56 PM |
| CRANSTON MARY B | Director | Jun 29, 2020 | Sale | $98.68 | 371 | 36,611 | 2,300 | Oct 30, 2020, 08:56 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 02, 2020 | Sale | $93.98 | 5,000 | 469,909 | 22,346 | Jul 07, 2020, 05:39 PM |
| CRANSTON MARY B | Director | Jun 29, 2020 | Option Exercise | $11.69 | 371 | 4,337 | 371 | Jul 01, 2020, 07:28 PM |
| CRANSTON MARY B | Director | Jun 30, 2020 | Option Exercise | $11.69 | 21,629 | 252,843 | 21,629 | Jul 01, 2020, 07:28 PM |
| CRANSTON MARY B | Director | Jun 29, 2020 | Sale | $98.68 | 371 | 36,611 | 0 | Jul 01, 2020, 07:28 PM |
| CRANSTON MARY B | Director | Jun 30, 2020 | Sale | $96.60 | 21,629 | 2,089,355 | 21,329 | Jul 01, 2020, 07:28 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jun 02, 2020 | Sale | $102.84 | 5,000 | 514,208 | 28,522 | Jun 04, 2020, 04:24 PM |
| Bauer Jake | Chief Business Officer | Apr 30, 2020 | Option Exercise | $50.41 | 293 | 14,771 | 57,784 | Jun 04, 2020, 04:20 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 18, 2020 | Sale | $125.00 | 10,000 | 1,250,000 | 29,122 | May 20, 2020, 04:55 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 11, 2020 | Sale | $101.86 | 25,000 | 2,546,469 | 63,522 | May 13, 2020, 05:15 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 04, 2020 | Sale | $58.48 | 5,000 | 292,387 | 77,736 | May 06, 2020, 07:07 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 30, 2020 | Option Exercise | $50.41 | 421 | 21,224 | 278,082 | May 04, 2020, 05:34 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 30, 2020 | Option Exercise | $1.51 | 11,500 | 17,328 | 289,582 | May 04, 2020, 05:34 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 16, 2020 | Sale | $55.00 | 1,000 | 55,000 | 76,796 | Apr 20, 2020, 06:10 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 08, 2020 | Sale | $50.00 | 1,500 | 75,000 | 77,796 | Apr 10, 2020, 06:27 PM |
| Harris Taylor C. | Chief Financial Officer | Apr 06, 2020 | Sale | $46.99 | 1,305 | 61,322 | 7,438 | Apr 07, 2020, 05:42 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 02, 2020 | Sale | $44.77 | 2,500 | 111,917 | 81,196 | Apr 06, 2020, 04:06 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Mar 02, 2020 | Sale | $64.45 | 5,000 | 322,246 | 85,688 | Mar 04, 2020, 05:42 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,968 | Mar 04, 2020, 05:40 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 04, 2018 | Sale | $47.57 | 3,000 | 142,700 | 76,268 | Mar 04, 2020, 05:40 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 03, 2020 | Sale | $69.36 | 5,000 | 346,821 | 87,777 | Feb 05, 2020, 08:22 PM |
| Fairey William | See Remarks | Feb 01, 2020 | Sale | $68.04 | 2,899 | 197,248 | 5,226 | Feb 03, 2020, 08:55 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 14, 2020 | Sale | $75.39 | 5,000 | 376,964 | 91,777 | Jan 14, 2020, 08:26 PM |
| Harris Taylor C. | Chief Financial Officer | Jan 06, 2020 | Sale | $68.45 | 1,683 | 115,203 | 4,993 | Jan 07, 2020, 07:39 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 06, 2020 | Sale | $68.45 | 12,687 | 868,439 | 96,777 | Jan 07, 2020, 07:39 PM |
| McDowell Robert Scott | Chief Scientific Officer | Jan 06, 2020 | Sale | $68.45 | 2,650 | 181,395 | 5,383 | Jan 07, 2020, 07:39 PM |
| LADD CYNTHIA J | General Counsel | Jan 06, 2020 | Sale | $68.45 | 1,849 | 126,566 | 2,851 | Jan 07, 2020, 07:36 PM |
| Bauer Jake | Chief Business Officer | Jan 03, 2020 | Option Exercise | $1.51 | 10,000 | 15,100 | 59,957 | Jan 07, 2020, 05:15 PM |
| Bauer Jake | Chief Business Officer | Jan 06, 2020 | Sale | $68.45 | 2,466 | 168,800 | 57,491 | Jan 07, 2020, 05:15 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 03, 2020 | Sale | $71.80 | 5,000 | 359,008 | 114,164 | Jan 03, 2020, 08:18 PM |
| Bauer Jake | Chief Business Officer | Dec 20, 2019 | Option Exercise | $11.15 | 17,500 | 195,050 | 62,498 | Dec 23, 2019, 09:07 PM |
| Bauer Jake | Chief Business Officer | Dec 20, 2019 | Sale | $70.07 | 18,916 | 1,325,421 | 43,582 | Dec 23, 2019, 09:07 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Dec 02, 2019 | Sale | $65.02 | 5,000 | 325,098 | 90,864 | Dec 04, 2019, 04:26 PM |
| Bauer Jake | Chief Business Officer | Nov 29, 2019 | Sale | $65.60 | 8,136 | 533,711 | 45,798 | Dec 02, 2019, 04:10 PM |
| Bauer Jake | Chief Business Officer | Nov 27, 2019 | Sale | $65.13 | 13,096 | 852,977 | 53,134 | Dec 02, 2019, 04:10 PM |
| Bauer Jake | Chief Business Officer | Oct 31, 2019 | Option Exercise | $40.07 | 162 | 6,491 | 66,230 | Nov 08, 2019, 07:51 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 31, 2019 | Option Exercise | $40.07 | 44 | 1,763 | 96,514 | Nov 06, 2019, 06:33 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Nov 04, 2019 | Sale | $59.07 | 5,000 | 295,364 | 91,514 | Nov 06, 2019, 06:33 PM |
| Lee June | EVP, Chief Development Officer | Sep 04, 2018 | Option Exercise | $11.95 | 364 | 4,350 | 15,565 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Aug 09, 2018 | Option Exercise | $11.95 | 363 | 4,338 | 15,201 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Feb 25, 2019 | Option Exercise | $11.95 | 3,000 | 35,850 | 22,157 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Jul 10, 2018 | Option Exercise | $11.95 | 364 | 4,350 | 14,838 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Dec 03, 2018 | Option Exercise | $11.95 | 364 | 4,350 | 19,157 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | May 31, 2018 | Option Exercise | $11.95 | 364 | 4,350 | 14,474 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Nov 06, 2018 | Option Exercise | $11.95 | 364 | 4,350 | 18,793 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | May 09, 2018 | Option Exercise | $11.95 | 4,500 | 53,775 | 14,110 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Oct 11, 2018 | Option Exercise | $11.95 | 2,500 | 29,875 | 18,429 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | May 02, 2018 | Option Exercise | $11.95 | 5,457 | 65,211 | 9,610 | Oct 29, 2019, 08:31 PM |
| Lee June | EVP, Chief Development Officer | Oct 01, 2018 | Option Exercise | $11.95 | 364 | 4,350 | 15,929 | Oct 29, 2019, 08:31 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 03, 2019 | Sale | $55.00 | 1,000 | 55,000 | 96,470 | Oct 04, 2019, 05:27 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 02, 2019 | Sale | $52.28 | 4,000 | 209,111 | 100,770 | Oct 04, 2019, 05:27 PM |
| Lee June | EVP, Chief Development Officer | Sep 23, 2019 | Option Exercise | $11.95 | 12,625 | 150,869 | 17,204 | Sep 24, 2019, 06:23 PM |
| Lee June | EVP, Chief Development Officer | Sep 23, 2019 | Sale | $59.51 | 13,051 | 776,724 | 13,275 | Sep 24, 2019, 06:23 PM |
| Bauer Jake | Chief Business Officer | Sep 20, 2019 | Option Exercise | $10.64 | 19,700 | 209,625 | 85,768 | Sep 24, 2019, 04:05 PM |
| Bauer Jake | Chief Business Officer | Sep 20, 2019 | Sale | $60.09 | 19,700 | 1,183,777 | 66,068 | Sep 24, 2019, 04:05 PM |
| Lee June | EVP, Chief Development Officer | Sep 19, 2019 | Option Exercise | $11.95 | 5,435 | 64,948 | 10,014 | Sep 20, 2019, 05:31 PM |
| Lee June | EVP, Chief Development Officer | Sep 19, 2019 | Sale | $57.08 | 5,435 | 310,254 | 4,579 | Sep 20, 2019, 05:31 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Sep 11, 2019 | Sale | $55.00 | 1,000 | 55,000 | 101,470 | Sep 12, 2019, 04:16 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Sep 03, 2019 | Sale | $52.15 | 4,000 | 208,585 | 104,570 | Sep 05, 2019, 04:05 PM |
| Lee June | EVP, Chief Development Officer | Aug 09, 2019 | Option Exercise | $11.95 | 4,565 | 54,552 | 9,144 | Aug 12, 2019, 08:40 PM |
| Lee June | EVP, Chief Development Officer | Aug 09, 2019 | Sale | $57.00 | 4,565 | 260,219 | 4,579 | Aug 12, 2019, 08:40 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Aug 08, 2019 | Sale | $55.09 | 1,000 | 55,090 | 106,470 | Aug 09, 2019, 05:11 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Aug 02, 2019 | Sale | $53.23 | 4,000 | 212,935 | 107,670 | Aug 05, 2019, 04:05 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 22, 2019 | Sale | $55.00 | 1,000 | 55,000 | 111,470 | Jul 23, 2019, 04:05 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 05, 2019 | Sale | $49.73 | 4,000 | 198,903 | 114,920 | Jul 08, 2019, 05:35 PM |
| Lee June | EVP, Chief Development Officer | Apr 30, 2019 | Option Exercise | $40.78 | 401 | 16,354 | 4,579 | Jun 03, 2019, 05:48 PM |
| Bauer Jake | Chief Business Officer | Apr 30, 2019 | Option Exercise | $40.78 | 313 | 12,765 | 66,068 | Jun 03, 2019, 05:48 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 30, 2019 | Option Exercise | $40.78 | 503 | 20,514 | 77,470 | Jun 03, 2019, 05:48 PM |
| Bauer Jake | Chief Business Officer | Jan 02, 2018 | Option Exercise | $12.25 | 5,000 | 61,250 | 71,777 | Apr 17, 2019, 08:25 PM |
| Bauer Jake | Chief Business Officer | Jan 02, 2018 | Sale | $42.89 | 5,000 | 214,466 | 67,877 | Apr 17, 2019, 08:25 PM |
| Harris Taylor C. | Chief Financial Officer | Apr 05, 2019 | Sale | $53.30 | 1,324 | 70,569 | 2,426 | Apr 09, 2019, 06:19 PM |
| Lee June | See Remarks | Mar 14, 2019 | Option Exercise | $11.95 | 1,758 | 21,008 | 4,178 | Mar 18, 2019, 05:32 PM |
| Sanofi | 10% Owner | Feb 13, 2019 | Sale | $37.66 | 4,168,899 | 157,000,736 | 0 | Feb 15, 2019, 06:05 AM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 07, 2019 | Sale | $44.11 | 2,770 | 122,197 | 76,967 | Jan 11, 2019, 08:18 PM |
| Lee June | See Remarks | Jan 07, 2019 | Option Exercise | $44.06 | 1,100 | 48,467 | 2,420 | Jan 09, 2019, 09:36 PM |
| Semigran Marc | Chief Medical Officer | Jan 07, 2019 | Option Exercise | $44.26 | 517 | 22,880 | 1,110 | Jan 09, 2019, 09:32 PM |
| Bauer Jake | Chief Business Officer | Jan 07, 2019 | Option Exercise | $42.98 | 570 | 24,496 | 60,755 | Jan 09, 2019, 09:21 PM |
| Lambing Joseph | See Remarks | Jan 07, 2019 | Option Exercise | $43.99 | 351 | 15,439 | 94,740 | Jan 09, 2019, 09:19 PM |
| McDowell Robert Scott | Chief Scientific Officer | Jan 07, 2019 | Option Exercise | $44.15 | 767 | 33,863 | 1,158 | Jan 09, 2019, 09:15 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 04, 2019 | Buy | $39.86 | 2,500 | 99,647 | 88,473 | Jan 08, 2019, 07:12 PM |
| Lambing Joseph | See Remarks | Oct 31, 2018 | Option Exercise | $42.16 | 302 | 12,732 | 94,216 | Dec 20, 2018, 09:30 PM |
| Semigran Marc | Chief Medical Officer | Oct 31, 2018 | Option Exercise | $42.16 | 302 | 12,732 | 302 | Dec 20, 2018, 09:23 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Dec 12, 2018 | Sale | $55.68 | 3,000 | 167,045 | 72,087 | Dec 13, 2018, 08:41 PM |
| Lee June | See Remarks | Oct 31, 2018 | Option Exercise | $42.16 | 344 | 14,503 | 770 | Dec 06, 2018, 08:13 PM |
| Lee June | See Remarks | Dec 03, 2018 | Option Exercise | $11.95 | 5,000 | 59,750 | 5,770 | Dec 06, 2018, 08:13 PM |
| Lee June | See Remarks | Dec 03, 2018 | Sale | $60.81 | 5,000 | 304,060 | 2,970 | Dec 06, 2018, 08:13 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 31, 2018 | Option Exercise | $42.16 | 138 | 5,818 | 75,087 | Nov 06, 2018, 07:32 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Nov 05, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 78,087 | Nov 06, 2018, 07:32 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Nov 05, 2018 | Sale | $56.57 | 3,000 | 169,716 | 77,587 | Nov 06, 2018, 07:32 PM |
| Bauer Jake | Chief Business Officer | Oct 31, 2018 | Option Exercise | $42.16 | 272 | 11,468 | 60,878 | Nov 06, 2018, 07:30 PM |
| Bauer Jake | Chief Business Officer | Nov 02, 2018 | Sale | $55.45 | 978 | 54,230 | 59,900 | Nov 06, 2018, 07:30 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,949 | Oct 05, 2018, 09:13 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 04, 2018 | Sale | $58.19 | 3,000 | 174,578 | 76,749 | Oct 05, 2018, 09:13 PM |
| Lee June | See Remarks | Sep 21, 2018 | Option Exercise | $11.95 | 5,000 | 59,750 | 5,426 | Sep 24, 2018, 08:26 PM |
| Lee June | See Remarks | Sep 21, 2018 | Sale | $63.13 | 5,000 | 315,652 | 1,334 | Sep 24, 2018, 08:26 PM |
| Semigran Marc | Chief Medical Officer | Sep 05, 2018 | Option Exercise | $15.95 | 3,600 | 57,420 | 3,600 | Sep 06, 2018, 05:00 PM |
| Semigran Marc | Chief Medical Officer | Sep 04, 2018 | Option Exercise | $15.95 | 41,400 | 660,330 | 41,400 | Sep 06, 2018, 05:00 PM |
| Semigran Marc | Chief Medical Officer | Sep 05, 2018 | Sale | $60.00 | 3,600 | 216,000 | 0 | Sep 06, 2018, 05:00 PM |
| Semigran Marc | Chief Medical Officer | Sep 04, 2018 | Sale | $59.49 | 41,400 | 2,463,006 | 0 | Sep 06, 2018, 05:00 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Sep 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,949 | Sep 06, 2018, 04:59 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Sep 04, 2018 | Sale | $59.33 | 3,000 | 178,004 | 75,449 | Sep 06, 2018, 04:59 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Aug 06, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,949 | Aug 08, 2018, 06:54 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Aug 06, 2018 | Sale | $57.47 | 3,000 | 172,410 | 77,149 | Aug 08, 2018, 06:54 PM |
| Bauer Jake | Chief Business Officer | Jul 23, 2018 | Option Exercise | $13.90 | 7,500 | 104,250 | 68,106 | Jul 25, 2018, 04:17 PM |
| Bauer Jake | Chief Business Officer | Jul 23, 2018 | Sale | $56.88 | 7,500 | 426,565 | 63,707 | Jul 25, 2018, 04:17 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 05, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,949 | Jul 06, 2018, 06:48 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 05, 2018 | Sale | $53.13 | 3,000 | 159,379 | 77,449 | Jul 06, 2018, 06:48 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jun 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,949 | Jun 06, 2018, 07:34 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jun 04, 2018 | Sale | $46.95 | 3,000 | 140,864 | 75,549 | Jun 06, 2018, 07:34 PM |
| Lee June | See Remarks | Apr 30, 2018 | Option Exercise | $33.15 | 426 | 14,122 | 426 | Jun 01, 2018, 04:25 PM |
| Lambing Joseph | See Remarks | Apr 30, 2018 | Option Exercise | $33.15 | 368 | 12,199 | 93,914 | Jun 01, 2018, 04:25 PM |
| Sanofi | 10% Owner | May 25, 2018 | Buy | $49.00 | 150,000 | 7,350,000 | 4,168,899 | May 29, 2018, 04:34 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 30, 2018 | Option Exercise | $33.15 | 578 | 19,161 | 74,968 | May 07, 2018, 09:47 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 04, 2018 | Option Exercise | $1.51 | 2,981 | 4,492 | 77,949 | May 07, 2018, 09:47 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | May 04, 2018 | Sale | $47.57 | 3,000 | 142,700 | 76,249 | May 07, 2018, 09:47 PM |
| Bauer Jake | Chief Business Officer | Apr 30, 2018 | Option Exercise | $33.15 | 348 | 11,536 | 62,125 | May 07, 2018, 05:43 PM |
| Bauer Jake | Chief Business Officer | May 03, 2018 | Sale | $48.95 | 1,519 | 74,355 | 60,606 | May 07, 2018, 05:43 PM |
| Bauer Jake | See Remarks | Apr 11, 2018 | Option Exercise | $12.25 | 5,000 | 61,250 | 66,777 | Apr 12, 2018, 08:32 PM |
| Bauer Jake | See Remarks | Apr 11, 2018 | Sale | $50.00 | 5,000 | 250,000 | 61,777 | Apr 12, 2018, 08:32 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,390 | Apr 05, 2018, 07:48 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 04, 2018 | Sale | $47.95 | 3,000 | 143,863 | 75,615 | Apr 05, 2018, 07:48 PM |
| Bauer Jake | See Remarks | Mar 26, 2018 | Option Exercise | $9.08 | 164 | 1,489 | 61,941 | Mar 28, 2018, 04:08 PM |
| Bauer Jake | See Remarks | Mar 26, 2018 | Sale | $50.95 | 164 | 8,356 | 61,777 | Mar 28, 2018, 04:08 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Mar 05, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,390 | Mar 07, 2018, 04:48 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Mar 05, 2018 | Sale | $61.07 | 3,000 | 183,205 | 74,390 | Mar 07, 2018, 04:48 PM |
| Bauer Jake | See Remarks | Feb 26, 2018 | Option Exercise | $9.08 | 5,102 | 46,326 | 66,879 | Feb 28, 2018, 07:34 PM |
| Bauer Jake | See Remarks | Feb 26, 2018 | Sale | $60.00 | 5,102 | 306,120 | 61,777 | Feb 28, 2018, 07:34 PM |
| Lambing Joseph | See Remarks | Feb 26, 2018 | Sale | $60.00 | 2,300 | 138,000 | 93,546 | Feb 28, 2018, 07:31 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 26, 2018 | Option Exercise | $1.51 | 5,000 | 7,534 | 79,390 | Feb 28, 2018, 07:29 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 26, 2018 | Sale | $60.00 | 5,000 | 300,000 | 74,390 | Feb 28, 2018, 07:29 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 05, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,390 | Feb 16, 2018, 08:00 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 05, 2018 | Sale | $51.05 | 3,000 | 153,139 | 76,436 | Feb 16, 2018, 08:00 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 12, 2018 | Option Exercise | $1.51 | 5,000 | 7,534 | 79,390 | Feb 16, 2018, 07:59 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 12, 2018 | Sale | $50.00 | 5,000 | 250,000 | 74,390 | Feb 16, 2018, 07:59 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 577,390 | Feb 16, 2018, 07:58 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 04, 2018 | Sale | $41.70 | 3,000 | 125,103 | 574,390 | Feb 16, 2018, 07:58 PM |
| Bauer Jake | See Remarks | Jan 09, 2018 | Option Exercise | $12.25 | 5,000 | 61,250 | 66,777 | Feb 15, 2018, 08:27 PM |
| Bauer Jake | See Remarks | Jan 09, 2018 | Sale | $45.00 | 5,000 | 225,000 | 61,777 | Feb 15, 2018, 08:27 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 05, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 77,390 | Feb 07, 2018, 06:37 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Feb 05, 2018 | Sale | $51.05 | 3,000 | 153,139 | 76,436 | Feb 07, 2018, 06:37 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 12, 2018 | Option Exercise | $1.51 | 5,000 | 7,534 | 514,117 | Jan 16, 2018, 06:47 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 12, 2018 | Sale | $50.00 | 5,000 | 250,000 | 509,117 | Jan 16, 2018, 06:47 PM |
| Lambing Joseph | See Remarks | Jan 12, 2018 | Sale | $50.00 | 5,000 | 250,000 | 95,846 | Jan 16, 2018, 06:46 PM |
| Bauer Jake | See Remarks | Jan 09, 2018 | Sale | $45.00 | 5,000 | 225,000 | 56,777 | Jan 10, 2018, 04:45 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 04, 2018 | Option Exercise | $1.51 | 3,000 | 4,520 | 512,117 | Jan 05, 2018, 05:27 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jan 04, 2018 | Sale | $41.70 | 3,000 | 125,103 | 509,117 | Jan 05, 2018, 05:27 PM |
| Third Rock Ventures III, L.P. | 10% Owner | Jan 03, 2018 | Sale | $42.00 | 816,326 | 34,285,773 | 680,272 | Jan 05, 2018, 04:30 PM |
| STARR KEVIN P | Director | Jan 03, 2018 | Sale | $42.00 | 816,326 | 34,285,773 | 680,272 | Jan 05, 2018, 04:30 PM |
| Bauer Jake | See Remarks | Jan 02, 2018 | Sale | $42.89 | 5,000 | 214,466 | 62,877 | Jan 03, 2018, 08:06 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Dec 21, 2017 | Option Exercise | $1.51 | 3,000 | 4,520 | 512,117 | Dec 26, 2017, 04:46 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Dec 21, 2017 | Sale | $41.09 | 3,000 | 123,268 | 509,117 | Dec 26, 2017, 04:46 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Nov 06, 2017 | Option Exercise | $1.51 | 4,300 | 6,479 | 513,417 | Nov 08, 2017, 06:04 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Nov 06, 2017 | Sale | $40.23 | 4,300 | 172,990 | 510,217 | Nov 08, 2017, 06:04 PM |
| Lambing Joseph | See Remarks | Oct 31, 2017 | Option Exercise | $11.56 | 1,128 | 13,040 | 100,846 | Nov 03, 2017, 07:47 PM |
| Bauer Jake | See Remarks | Oct 31, 2017 | Option Exercise | $11.56 | 1,232 | 14,242 | 66,777 | Nov 03, 2017, 07:45 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 31, 2017 | Option Exercise | $11.56 | 954 | 11,028 | 509,117 | Nov 03, 2017, 07:45 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 04, 2017 | Option Exercise | $1.51 | 4,300 | 6,479 | 512,463 | Oct 06, 2017, 06:49 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 04, 2017 | Sale | $40.86 | 4,300 | 175,699 | 508,163 | Oct 06, 2017, 06:49 PM |
| STARR KEVIN P | Director | Oct 03, 2017 | Sale | $40.28 | 75,313 | 3,033,577 | 70,763 | Oct 04, 2017, 04:00 PM |
| Third Rock Ventures II, L.P. | 10% Owner | Sep 26, 2017 | Sale | $43.00 | 400,000 | 17,200,000 | 6,885,104 | Sep 27, 2017, 04:01 PM |
| Third Rock Ventures II, L.P. | 10% Owner | Sep 25, 2017 | Sale | $43.00 | 201,400 | 8,660,200 | 7,285,104 | Sep 27, 2017, 04:01 PM |
| STARR KEVIN P | Director | Sep 26, 2017 | Sale | $43.00 | 400,000 | 17,200,000 | 6,885,104 | Sep 27, 2017, 04:00 PM |
| STARR KEVIN P | Director | Sep 25, 2017 | Sale | $43.00 | 201,400 | 8,660,200 | 7,285,104 | Sep 27, 2017, 04:00 PM |
| Third Rock Ventures II, L.P. | 10% Owner | Sep 08, 2017 | Sale | $41.01 | 201,250 | 8,252,499 | 7,487,404 | Sep 12, 2017, 04:05 PM |
| Third Rock Ventures II, L.P. | 10% Owner | Sep 11, 2017 | Sale | $44.25 | 20,000 | 885,080 | 57,651 | Sep 12, 2017, 04:05 PM |
| STARR KEVIN P | Director | Sep 08, 2017 | Sale | $41.01 | 201,250 | 8,252,499 | 7,487,404 | Sep 12, 2017, 04:05 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Sep 05, 2017 | Option Exercise | $1.51 | 4,300 | 6,479 | 512,463 | Sep 07, 2017, 04:06 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Sep 05, 2017 | Sale | $43.02 | 4,300 | 185,004 | 508,463 | Sep 07, 2017, 04:06 PM |
| Lambing Joseph | See Remarks | Aug 22, 2017 | Sale | $45.00 | 5,000 | 225,000 | 99,718 | Aug 24, 2017, 04:05 PM |
| YARNO WENDY L | Director | Aug 14, 2017 | Buy | $35.50 | 1,408 | 49,984 | 1,408 | Aug 16, 2017, 04:33 PM |
| Lambing Joseph | See Remarks | Aug 15, 2017 | Sale | $40.00 | 5,000 | 200,000 | 104,718 | Aug 16, 2017, 04:32 PM |
| Sanofi | 10% Owner | Aug 14, 2017 | Buy | $35.50 | 350,000 | 12,425,000 | 4,018,899 | Aug 16, 2017, 07:31 AM |
| Lambing Joseph | See Remarks | Aug 08, 2017 | Sale | $35.00 | 5,000 | 175,000 | 109,718 | Aug 09, 2017, 05:16 PM |
| Lambing Joseph | See Remarks | Aug 07, 2017 | Sale | $27.50 | 10,000 | 275,000 | 119,718 | Aug 09, 2017, 05:16 PM |
| Bauer Jake | See Remarks | Aug 07, 2017 | Sale | $28.33 | 15,000 | 425,000 | 75,545 | Aug 09, 2017, 05:15 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Aug 04, 2017 | Option Exercise | $1.51 | 4,300 | 6,479 | 512,463 | Aug 04, 2017, 09:31 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Aug 04, 2017 | Sale | $16.62 | 4,300 | 71,465 | 508,163 | Aug 04, 2017, 09:31 PM |
| Bauer Jake | See Remarks | Jul 25, 2017 | Sale | $15.02 | 4,333 | 65,060 | 80,545 | Jul 27, 2017, 05:11 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 25, 2017 | Option Exercise | $1.51 | 31,850 | 48,093 | 541,151 | Jul 27, 2017, 05:11 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Jul 25, 2017 | Sale | $15.00 | 32,988 | 494,902 | 508,163 | Jul 27, 2017, 05:11 PM |
| Bauer Jake | See Remarks | Apr 28, 2017 | Option Exercise | $11.09 | 978 | 10,848 | 84,878 | May 16, 2017, 01:49 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 28, 2017 | Option Exercise | $11.09 | 1,259 | 13,965 | 509,301 | May 16, 2017, 01:45 PM |
| Lambing Joseph | See Remarks | Apr 28, 2017 | Option Exercise | $11.09 | 1,135 | 12,590 | 124,718 | May 16, 2017, 01:45 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Mar 20, 2017 | Option Exercise | $1.51 | 1,200 | 1,812 | 509,454 | Mar 22, 2017, 08:39 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Mar 20, 2017 | Sale | $15.00 | 1,412 | 21,180 | 508,042 | Mar 22, 2017, 08:39 PM |
| Bauer Jake | See Remarks | Mar 20, 2017 | Sale | $15.00 | 667 | 10,005 | 83,900 | Mar 22, 2017, 08:37 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 29, 2016 | Option Exercise | $8.50 | 2,279 | 19,372 | 484,444 | Mar 01, 2017, 09:04 PM |
| Lambing Joseph | See Remarks | Oct 31, 2016 | Option Exercise | $10.03 | 1,263 | 12,668 | 123,583 | Nov 02, 2016, 05:42 PM |
| Bauer Jake | See Remarks | Oct 31, 2016 | Option Exercise | $10.03 | 1,519 | 15,236 | 84,567 | Nov 02, 2016, 05:41 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Oct 31, 2016 | Option Exercise | $10.03 | 898 | 9,007 | 508,254 | Nov 02, 2016, 05:40 PM |
| Sanofi | 10% Owner | Oct 03, 2016 | Buy | $15.00 | 450,000 | 6,750,000 | 3,668,899 | Oct 05, 2016, 09:00 AM |
| GIANAKAKOS ANASTASIOS | President and CEO | Apr 29, 2016 | Buy | $8.50 | 2,279 | 19,372 | 484,444 | May 06, 2016, 06:24 PM |
| Bauer Jake | See Remarks | Apr 29, 2016 | Option Exercise | $8.50 | 1,416 | 12,036 | 83,048 | May 06, 2016, 04:51 PM |
| Lambing Joseph | See Remarks | Apr 29, 2016 | Option Exercise | $8.50 | 1,233 | 10,481 | 122,320 | May 06, 2016, 04:21 PM |
| Fox Jonathan C | Chief Medical Officer | Apr 29, 2016 | Option Exercise | $8.50 | 1,807 | 15,360 | 240,997 | May 06, 2016, 04:20 PM |
| Fox Jonathan C | Chief Medical Officer | Nov 03, 2015 | Buy | $10.00 | 3,000 | 30,000 | 239,190 | Nov 05, 2015, 08:41 PM |
| GIANAKAKOS ANASTASIOS | President and CEO | Nov 03, 2015 | Buy | $10.00 | 1,350 | 13,500 | 482,165 | Nov 05, 2015, 08:38 PM |
| PERRY MARK L | Director | Nov 03, 2015 | Buy | $10.00 | 5,000 | 50,000 | 25,408 | Nov 05, 2015, 08:38 PM |
| Sanofi | 10% Owner | Nov 03, 2015 | Buy | $10.00 | 900,000 | 9,000,000 | 3,218,899 | Nov 05, 2015, 02:37 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| CRANSTON MARY B | Director | 06/30/2020 | 252,843 |
| CRANSTON MARY B | Director | 06/29/2020 | 4,337 |
| CRANSTON MARY B | Director | 06/30/2020 | 2,089,355 |
| CRANSTON MARY B | Director | 06/29/2020 | 36,611 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/02/2020 | 469,909 |
| CRANSTON MARY B | Director | 06/29/2020 | 4,337 |
| CRANSTON MARY B | Director | 06/30/2020 | 252,843 |
| CRANSTON MARY B | Director | 06/29/2020 | 36,611 |
| CRANSTON MARY B | Director | 06/30/2020 | 2,089,355 |
| GIANAKAKOS ANASTASIOS | President and CEO | 06/02/2020 | 514,208 |
| Bauer Jake | Chief Business Officer | 04/30/2020 | 14,771 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/18/2020 | 1,250,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/11/2020 | 2,546,469 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/04/2020 | 292,387 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/30/2020 | 21,224 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/30/2020 | 17,328 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/16/2020 | 55,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/08/2020 | 75,000 |
| Harris Taylor C. | Chief Financial Officer | 04/06/2020 | 61,322 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/02/2020 | 111,917 |
| GIANAKAKOS ANASTASIOS | President and CEO | 03/02/2020 | 322,246 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/04/2018 | 142,700 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/03/2020 | 346,821 |
| Fairey William | See Remarks | 02/01/2020 | 197,248 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/14/2020 | 376,964 |
| Harris Taylor C. | Chief Financial Officer | 01/06/2020 | 115,203 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/06/2020 | 868,439 |
| McDowell Robert Scott | Chief Scientific Officer | 01/06/2020 | 181,395 |
| LADD CYNTHIA J | General Counsel | 01/06/2020 | 126,566 |
| Bauer Jake | Chief Business Officer | 01/03/2020 | 15,100 |
| Bauer Jake | Chief Business Officer | 01/06/2020 | 168,800 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/03/2020 | 359,008 |
| Bauer Jake | Chief Business Officer | 12/20/2019 | 195,050 |
| Bauer Jake | Chief Business Officer | 12/20/2019 | 1,325,421 |
| GIANAKAKOS ANASTASIOS | President and CEO | 12/02/2019 | 325,098 |
| Bauer Jake | Chief Business Officer | 11/29/2019 | 533,711 |
| Bauer Jake | Chief Business Officer | 11/27/2019 | 852,977 |
| Bauer Jake | Chief Business Officer | 10/31/2019 | 6,491 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/31/2019 | 1,763 |
| GIANAKAKOS ANASTASIOS | President and CEO | 11/04/2019 | 295,364 |
| Lee June | EVP, Chief Development Officer | 09/04/2018 | 4,350 |
| Lee June | EVP, Chief Development Officer | 08/09/2018 | 4,338 |
| Lee June | EVP, Chief Development Officer | 02/25/2019 | 35,850 |
| Lee June | EVP, Chief Development Officer | 07/10/2018 | 4,350 |
| Lee June | EVP, Chief Development Officer | 12/03/2018 | 4,350 |
| Lee June | EVP, Chief Development Officer | 05/31/2018 | 4,350 |
| Lee June | EVP, Chief Development Officer | 11/06/2018 | 4,350 |
| Lee June | EVP, Chief Development Officer | 05/09/2018 | 53,775 |
| Lee June | EVP, Chief Development Officer | 10/11/2018 | 29,875 |
| Lee June | EVP, Chief Development Officer | 05/02/2018 | 65,211 |
| Lee June | EVP, Chief Development Officer | 10/01/2018 | 4,350 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/03/2019 | 55,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/02/2019 | 209,111 |
| Lee June | EVP, Chief Development Officer | 09/23/2019 | 150,869 |
| Lee June | EVP, Chief Development Officer | 09/23/2019 | 776,724 |
| Bauer Jake | Chief Business Officer | 09/20/2019 | 209,625 |
| Bauer Jake | Chief Business Officer | 09/20/2019 | 1,183,777 |
| Lee June | EVP, Chief Development Officer | 09/19/2019 | 64,948 |
| Lee June | EVP, Chief Development Officer | 09/19/2019 | 310,254 |
| GIANAKAKOS ANASTASIOS | President and CEO | 09/11/2019 | 55,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 09/03/2019 | 208,585 |
| Lee June | EVP, Chief Development Officer | 08/09/2019 | 54,552 |
| Lee June | EVP, Chief Development Officer | 08/09/2019 | 260,219 |
| GIANAKAKOS ANASTASIOS | President and CEO | 08/08/2019 | 55,090 |
| GIANAKAKOS ANASTASIOS | President and CEO | 08/02/2019 | 212,935 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/22/2019 | 55,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/05/2019 | 198,903 |
| Lee June | EVP, Chief Development Officer | 04/30/2019 | 16,354 |
| Bauer Jake | Chief Business Officer | 04/30/2019 | 12,765 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/30/2019 | 20,514 |
| Bauer Jake | Chief Business Officer | 01/02/2018 | 61,250 |
| Bauer Jake | Chief Business Officer | 01/02/2018 | 214,466 |
| Harris Taylor C. | Chief Financial Officer | 04/05/2019 | 70,569 |
| Lee June | See Remarks | 03/14/2019 | 21,008 |
| Sanofi | 10% Owner | 02/13/2019 | 157,000,736 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/07/2019 | 122,197 |
| Lee June | See Remarks | 01/07/2019 | 48,467 |
| Semigran Marc | Chief Medical Officer | 01/07/2019 | 22,880 |
| Bauer Jake | Chief Business Officer | 01/07/2019 | 24,496 |
| Lambing Joseph | See Remarks | 01/07/2019 | 15,439 |
| McDowell Robert Scott | Chief Scientific Officer | 01/07/2019 | 33,863 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/04/2019 | 99,647 |
| Lambing Joseph | See Remarks | 10/31/2018 | 12,732 |
| Semigran Marc | Chief Medical Officer | 10/31/2018 | 12,732 |
| GIANAKAKOS ANASTASIOS | President and CEO | 12/12/2018 | 167,045 |
| Lee June | See Remarks | 10/31/2018 | 14,503 |
| Lee June | See Remarks | 12/03/2018 | 59,750 |
| Lee June | See Remarks | 12/03/2018 | 304,060 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/31/2018 | 5,818 |
| GIANAKAKOS ANASTASIOS | President and CEO | 11/05/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 11/05/2018 | 169,716 |
| Bauer Jake | Chief Business Officer | 10/31/2018 | 11,468 |
| Bauer Jake | Chief Business Officer | 11/02/2018 | 54,230 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/04/2018 | 174,578 |
| Lee June | See Remarks | 09/21/2018 | 59,750 |
| Lee June | See Remarks | 09/21/2018 | 315,652 |
| Semigran Marc | Chief Medical Officer | 09/05/2018 | 57,420 |
| Semigran Marc | Chief Medical Officer | 09/04/2018 | 660,330 |
| Semigran Marc | Chief Medical Officer | 09/05/2018 | 216,000 |
| Semigran Marc | Chief Medical Officer | 09/04/2018 | 2,463,006 |
| GIANAKAKOS ANASTASIOS | President and CEO | 09/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 09/04/2018 | 178,004 |
| GIANAKAKOS ANASTASIOS | President and CEO | 08/06/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 08/06/2018 | 172,410 |
| Bauer Jake | Chief Business Officer | 07/23/2018 | 104,250 |
| Bauer Jake | Chief Business Officer | 07/23/2018 | 426,565 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/05/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/05/2018 | 159,379 |
| GIANAKAKOS ANASTASIOS | President and CEO | 06/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 06/04/2018 | 140,864 |
| Lee June | See Remarks | 04/30/2018 | 14,122 |
| Lambing Joseph | See Remarks | 04/30/2018 | 12,199 |
| Sanofi | 10% Owner | 05/25/2018 | 7,350,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/30/2018 | 19,161 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/04/2018 | 4,492 |
| GIANAKAKOS ANASTASIOS | President and CEO | 05/04/2018 | 142,700 |
| Bauer Jake | Chief Business Officer | 04/30/2018 | 11,536 |
| Bauer Jake | Chief Business Officer | 05/03/2018 | 74,355 |
| Bauer Jake | See Remarks | 04/11/2018 | 61,250 |
| Bauer Jake | See Remarks | 04/11/2018 | 250,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/04/2018 | 143,863 |
| Bauer Jake | See Remarks | 03/26/2018 | 1,489 |
| Bauer Jake | See Remarks | 03/26/2018 | 8,356 |
| GIANAKAKOS ANASTASIOS | President and CEO | 03/05/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 03/05/2018 | 183,205 |
| Bauer Jake | See Remarks | 02/26/2018 | 46,326 |
| Bauer Jake | See Remarks | 02/26/2018 | 306,120 |
| Lambing Joseph | See Remarks | 02/26/2018 | 138,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/26/2018 | 7,534 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/26/2018 | 300,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/05/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/05/2018 | 153,139 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/12/2018 | 7,534 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/12/2018 | 250,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/04/2018 | 125,103 |
| Bauer Jake | See Remarks | 01/09/2018 | 61,250 |
| Bauer Jake | See Remarks | 01/09/2018 | 225,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/05/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 02/05/2018 | 153,139 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/12/2018 | 7,534 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/12/2018 | 250,000 |
| Lambing Joseph | See Remarks | 01/12/2018 | 250,000 |
| Bauer Jake | See Remarks | 01/09/2018 | 225,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/04/2018 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 01/04/2018 | 125,103 |
| Third Rock Ventures III, L.P. | 10% Owner | 01/03/2018 | 34,285,773 |
| STARR KEVIN P | Director | 01/03/2018 | 34,285,773 |
| Bauer Jake | See Remarks | 01/02/2018 | 214,466 |
| GIANAKAKOS ANASTASIOS | President and CEO | 12/21/2017 | 4,520 |
| GIANAKAKOS ANASTASIOS | President and CEO | 12/21/2017 | 123,268 |
| GIANAKAKOS ANASTASIOS | President and CEO | 11/06/2017 | 6,479 |
| GIANAKAKOS ANASTASIOS | President and CEO | 11/06/2017 | 172,990 |
| Lambing Joseph | See Remarks | 10/31/2017 | 13,040 |
| Bauer Jake | See Remarks | 10/31/2017 | 14,242 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/31/2017 | 11,028 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/04/2017 | 6,479 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/04/2017 | 175,699 |
| STARR KEVIN P | Director | 10/03/2017 | 3,033,577 |
| Third Rock Ventures II, L.P. | 10% Owner | 09/26/2017 | 17,200,000 |
| Third Rock Ventures II, L.P. | 10% Owner | 09/25/2017 | 8,660,200 |
| STARR KEVIN P | Director | 09/26/2017 | 17,200,000 |
| STARR KEVIN P | Director | 09/25/2017 | 8,660,200 |
| Third Rock Ventures II, L.P. | 10% Owner | 09/08/2017 | 8,252,499 |
| Third Rock Ventures II, L.P. | 10% Owner | 09/11/2017 | 885,080 |
| STARR KEVIN P | Director | 09/08/2017 | 8,252,499 |
| GIANAKAKOS ANASTASIOS | President and CEO | 09/05/2017 | 6,479 |
| GIANAKAKOS ANASTASIOS | President and CEO | 09/05/2017 | 185,004 |
| Lambing Joseph | See Remarks | 08/22/2017 | 225,000 |
| YARNO WENDY L | Director | 08/14/2017 | 49,984 |
| Lambing Joseph | See Remarks | 08/15/2017 | 200,000 |
| Sanofi | 10% Owner | 08/14/2017 | 12,425,000 |
| Lambing Joseph | See Remarks | 08/08/2017 | 175,000 |
| Lambing Joseph | See Remarks | 08/07/2017 | 275,000 |
| Bauer Jake | See Remarks | 08/07/2017 | 425,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 08/04/2017 | 6,479 |
| GIANAKAKOS ANASTASIOS | President and CEO | 08/04/2017 | 71,465 |
| Bauer Jake | See Remarks | 07/25/2017 | 65,060 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/25/2017 | 48,093 |
| GIANAKAKOS ANASTASIOS | President and CEO | 07/25/2017 | 494,902 |
| Bauer Jake | See Remarks | 04/28/2017 | 10,848 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/28/2017 | 13,965 |
| Lambing Joseph | See Remarks | 04/28/2017 | 12,590 |
| GIANAKAKOS ANASTASIOS | President and CEO | 03/20/2017 | 1,812 |
| GIANAKAKOS ANASTASIOS | President and CEO | 03/20/2017 | 21,180 |
| Bauer Jake | See Remarks | 03/20/2017 | 10,005 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/29/2016 | 19,372 |
| Lambing Joseph | See Remarks | 10/31/2016 | 12,668 |
| Bauer Jake | See Remarks | 10/31/2016 | 15,236 |
| GIANAKAKOS ANASTASIOS | President and CEO | 10/31/2016 | 9,007 |
| Sanofi | 10% Owner | 10/03/2016 | 6,750,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 04/29/2016 | 19,372 |
| Bauer Jake | See Remarks | 04/29/2016 | 12,036 |
| Lambing Joseph | See Remarks | 04/29/2016 | 10,481 |
| Fox Jonathan C | Chief Medical Officer | 04/29/2016 | 15,360 |
| Fox Jonathan C | Chief Medical Officer | 11/03/2015 | 30,000 |
| GIANAKAKOS ANASTASIOS | President and CEO | 11/03/2015 | 13,500 |
| PERRY MARK L | Director | 11/03/2015 | 50,000 |
| Sanofi | 10% Owner | 11/03/2015 | 9,000,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR MYOKARDIA, INC.
LOADING...